CSIMarket Company Name, Ticker, Suppliers, else..


Sutro Biopharma Inc   (NASDAQ: STRO)
Other Ticker:  
 

Sutro Biopharma Inc

STRO's Fundamental analysis



Sutro Biopharma Inc 's sales fell by -49.66 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2582

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Sutro Biopharma Inc net loss decreased from $-49 millions, to $-49 millions in III. Quarter 2024,

• More on STRO's Growth


Sutro Biopharma Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.78 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.02.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.67.


• More on STRO's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,157,950
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 7.95
 Tangible Book Value (Per Share $) 1.36

Sutro Biopharma Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.78 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.02.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.67.

Sutro Biopharma Inc Price to Book Ratio is at 1.48 lower than Industry Avg. of 406.6. and higher than S&P 500 Avg. of 0.01

• More on STRO's Valuation

•  Market Capitalization (Millions $) 165
•  Shares Outstanding (Millions) 82
•  Employees 139
•  Revenues (TTM) (Millions $) 161
•  Net Income (TTM) (Millions $) -124
•  Cash Flow (TTM) (Millions $) 93
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,157,950
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 7.95
•  Tangible Book Value (Per Share $) 1.36

•  Market Capitalization (Millions $) 165
•  Shares Outstanding (Millions) 82
•  Employees 139
•  Revenues (TTM) (Millions $) 161
•  Net Income (TTM) (Millions $) -124
•  Cash Flow (TTM) (Millions $) 93
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 3.09
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 3.06
•  Asset Turnover Ratio (TTM) 0.35
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com